RESEARCH TRIANGLE PARK, N.C. & BRUSSELS, Belgium--(BUSINESS WIRE)--A scientific symposium which featured the latest information on potential therapeutic applications of intravenous immune globulin (IVIG) in neurological disorders was presented yesterday at the 11th Congress of the European Federation of Neurological Societies in Brussels, Belgium. The program, entitled “Advances in the Use of IVIG in Neurological Disorders,” was sponsored by Talecris Biotherapeutics, Inc. (http://www.talecris.com). The program featured presentations and discussions of the growing evidence supporting use of IVIG to treat a variety of neurological disorders including autoimmune neuropathies and other autoimmune neurological disorders.
